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PURPOSE: To evaluate the oncological outcome of patients with grade I chondrosarcomas according to the type of
surgical treatment performed, since there is still controversy regarding the need for aggressive resections to reach a successful
outcome.
MATERIALS AND METHODS: The records of 23 patients with grade I chondrosarcomas were reviewed. The mean
age was 38.4 years, ranging from 11 to 70 years; 52% were men and 48% were women. The femur was the site of 13 tumors.
The tumors were staged as IA (17, 74%) and IB (6, 26%). Regarding tumor location, 74% (17) were medullary, 22% (5) were
peripheral, and 4% (1) was indeterminate. Tumor size ranged from 2 to 25 cm, mean 7.9 cm. Regarding the surgical
procedure, 11 patients underwent intralesional resection, 9 patients underwent wide resection, and 3 underwent radical
resection. The follow-up period ranged from 24 to 192 months.
RESULTS: None of the patients developed local recurrence or metastases; 7 patients had other general complications.
CONCLUSIONS: This data supports the use of less aggressive procedures for treatment of low-grade chondrosarcomas.
KEYWORDS: Chondrosarcoma. Treatment outcome. Curettage.
Chondrosarcoma is the second most frequent bone sar-
coma, occurring mainly in the fourth and fifth decades.1
Classic chondrosarcomas can be divided into grades I, II,
and III.2 Other histological types include juxta-cortical,
clear cell, mesenchymal, and dedifferentiated chondrosar-
comas. Chondrosarcomas may be classified as medullary or
peripheral, according to the position in relation to the med-
ullary bone. Chondrosarcomas can also be classified as pri-
mary or as secondary when it originates from a previously
benign cartilaginous lesion.
A relationship between the prognosis and the histologi-
cal grading and surgical treatment of chondrosarcomas has
been identified.3, 4 Surgery is the only effective method for
treatment of chondrosarcomas since these tumors do not re-
spond to radiotherapy or chemotherapy. Grade I tumors have
a better prognosis than grades II and III, with a lower inci-
dence of metastases.5,6
The presence of local recurrence and the type of surgi-
cal treatment have been correlated. Some authors do not
recommend less aggressive surgical treatment because of
the greater incidence of local recurrence.5,7-9 However,
intralesional resection with the use of a local adjuvant
(such as methyl-methacrylate) has been applied with good
results in the treatment of aggressive borderline benign
tumors such giant cell tumors of the bone. The same tech-
nique has been used in grade I chondrosarcomas in some
situations.10-12
The purpose of this study was to evaluate the oncologi-
cal outcomes of patients with classic grade I chondrosarco-
mas compared to the type of surgery performed in order to
evaluate the safety of the less aggressive procedures.
122
CLINICS 60(2):121-126, 2005Relationship between surgical procedure and outcome for patients
Etchebehere M et al.
MATERIALS AND METHODS
Patient selection
A restrospective analysis was performed on 39 patients
with grade I chondrosarcomas as confirmed by histology.
The histological analysis was reviewed by a pathologist
experienced in bone pathology. Only patients with at least
24 months of postoperative follow-up (23) were included.
Eleven patients were women and 12 were men. Patients’
ages ranged from 11 to 70 years of age, mean age 38.4 years.
All tumors were surgically removed. Radiographs of the
tumor site and thorax were performed on all patients in the
follow-up period. The patients were followed up every 3
months during the first year, every 6 months during the sec-
ond to fifth years, and every 12 months for up to 10 years
after 5 years.
Classification and staging
Tumors were staged by the method described by
Enneking et al.13 and accepted by the Musculoskeletal
Tumor Society (MSTS). Tumors were also classified as med-
ullary, peripheral, or indeterminate. The largest diameter of
the tumor was determined for the evaluation of prognosis.
Preoperative staging for all patients consisted of chest
and bone radiographies. One patient also had a preoperative
skeletal CT scan, and 1 had a preoperative skeletal MRI.
Surgical treatment
The resections were either intralesional, wide, or radi-
cal. Intralesional resections were performed on 11 patients.
This resection consisted of a simple curettage or was asso-
ciated with local adjuvant (cauterization and use of methyl-
methacrylate) (Figure 1). Wide resection was performed in
9 patients and consisted of an in-block resection of the le-
sion with wide margins followed or not by implantation of
an endoprosthesis. Radical resections were performed in 3
patients and consisted of 2 amputations and 1 total
scapulectomy.
Oncological analysis
The oncological analysis was based on the presence of
local recurrences, metastases, or death related to the tumor.
It was classified as:
1. Alive and free of disease;
2. Alive with disease (local recurrence or metastasis);
3. Dead by disease;
4. Dead without disease.
Statistical analysis
The surgical procedures were divided into two groups:
intralesional resections and wide/radical resections. The
oncological results were compared between the two groups.
The Fisher exact test and the Mann-Whitney test were used
and the level of significance adopted was 5%.
RESULTS
The median follow-up after surgery ranged from 24 to
192 months, mean 71.9 months, median 60 months. In the
intralesional group the mean was 64 months, median 40
months. In the wide/radical group the mean was 79 months,
median was 60 months (P = .3). Five patients were lost to
long-term follow-up: 1 at 51 months, 2 at 60 months, 1 at
Figure 1 - Patient with a grade I chondrosarcoma who underwent an intralesional resection. A) and B) Preoperative radiograph of the distal femur
showing well-organized calcific rings within the matrix and cortical bulging and endosteal erosion indicative of a low-grade chondrosarcoma.
C) Postoperative radiograph. The tumor area was filled with methyl-methacrylate and Ender nails. D) One year after surgery; radiograph shows
callus formation at the site of a non-displaced fracture that was treated conservatively. E) Functional aspect (knee flexion) of the surgically treated
limb 1 month after surgery.
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84 months, and 1 at 120 months. Four of these patients were
from the wide/radical group, and 1 patient was from the
intralesional group (Table 1).
The most common location of the chondrosarcoma was
the femur (39%).
Histopathology and classification results
Seventeen patients (74%) had medullary tumors, 5 pa-
tients (21.7%) had peripheral tumors, and 1 patient had an
indeterminate lesion. The largest diameter of the tumors
ranged from 2 cm to 25 cm, mean 7.9 cm. The lesions were
divided into 2 groups: 18 patients (78%) had lesions smaller
than 10 cm, and 5 patients (22%) had lesions larger than
10 cm.
Seventeen lesions (74%) were staged as IA and 6 (26%)
as IB.
Surgical results
Seven patients had postoperative complications. The
most common complication was fracture (3/7 patients).
These 3 patients had tumors in the distal femur, and the frac-
tures occurred at the first, fifth, and twelfth postoperative
months. One patient (1/7) had a loosening of the prosthe-
sis in the distal femur 4 years after surgery. One patient (1/
7) had a deep venous thrombosis and a non-union at the
site of tumor resection, also in the distal femur. One patient
(1/7) developed hip pain with degenerative joint disease
after an intralesional resection of a femoral head chondro-
sarcoma with electrical cauterization and filling with me-
thyl-methacrylate. One patient (1/7) developed fibular
neuropraxia with spontaneous regression after 4 postopera-
tive months.
Oncologic result
All 23 patients were alive with no evidence of disease
at the last follow-up. No patient needed resection of
metastases or local recurrence during the follow-up period.
DISCUSSION
When Lichtenstein et al.14 established the criteria for dif-
ferentiating benign from malignant cartilaginous tumors,
they made it possible to grade chondrosarcomas and de-
fine the prognosis of each histological type. Depending on
the histological type—I, II, or III—the surgical strategy will
differ. However, prognostic analysis using histology type
of chondrosarcomas is not adequate due to the distinct
behavior and aggressiveness of each type, which may lead
to erroneous results. Any study of chondrosarcomas should
Table 1 - Results with grade I chondrosarcomas regarding location, origin, staging, size, type of surgery, complications,
follow-up time, and oncological and functional outcome.
No Location Origin Stage Diameter (cm) Type of Surgery Complications Follow-up Oncologic
1 Phal I IB —- R 60 A
2 Prox M IA 4 Cu + LA DP 192 A
3 Prox P IA 6 Wide 51 A
4 Prox M IB 8 Wide neuropraxia 154 A
5 Dist M IA 6 Wide + end loosening 144 A
6 Scap P IB 25 R 120 A
7 Dist M IA 10 Cu + LA 60 A
8 Phal M IB 6 R 120 A
9 Dist M IA 15 Cu + LA fracture 108 A
10 Diap M IA 15 Cu + LA 84 A
11 Prox M IA 11 Wide + end 84 A
12 Prox M IA 7 Wide + end 60 A
13 Dist M IA 5 Cu + LA Fracture 67 A
14 Dist M IA 2 Wide DVT+DJD 60 A
15 Dist M IA 5 Cu + LA 29 A
16 Dist M IA 10 Cu + LA Fracture 40 A
17 Dist M IA 10 Cu + LA 29 A
18 Dist M IB 2 Cu 37 A
19 Isch P IB 4 Wide 39 A
20 Metat P IA 3 Wide 33 A
21 Prox M IA 2 Cu 35 A
22 Prox P IA 16 Wide 24 A
23 Prox M IA 3 Cu 24 A
Source: IOT HC FMUSP. I = indeterminate ; M = medullary ; P = peripheral; Prox = proximal femur ; Diap = femoral diaphisis; Dist = distal
femur; Phal = phalanx; Scap = scapula; Isch = ischium ; Metat = metatarsal; Cu = curettage; LA = local adjuvant; End = endoprosthesis; R =
radical; DVT = deep venous thrombosis; DJD = degenerative joint disease; A = Alive and free of disease
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differentiate grade I lesions, which have a good prognosis.
However, the differentiation of each tumor grade is not
an easy task. When biopsies are performed on chondrosar-
comas, a correct diagnosis is reached in 96% of the cases,
but the correct tumor grade only occurs in 46% of cases.15
Therefore, it is unsafe to use histology alone to plan treat-
ment for patients with chondrosarcomas.15 The tumor must
be considered malignant if the radiographic findings point
to this, even when histology indicates otherwise.16 Clini-
cal, radiographic, and histologic evaluations must be used
together to define the tumor grade.8,10 The incisional biopsy
is not necessary in all cases, but it should be performed when
diagnosis is in doubt.
Medullary lesions relate to a higher incidence of
metastases, but local recurrence is about the same as with
peripheral lesions.5 Our data are similar to those of Bauer
et al.10 in which the follow-up of 40 grade I medullary le-
sions showed only 3 local recurrences and no metastases.
In the present series, no metastases or local recurrences oc-
curred regardless of the medullary or peripheral nature of
the lesions.
Neither has a relationship of tumor size to survival been
clearly established. Lower survival rates in 113 patients with
pelvic or proximal femoral chondrosarcomas larger than 13
cm17 and in patients with tumors larger than 10 cm6,18 have
been reported. However, in a study of pelvic chondrosarco-
mas, tumor size did not influence the occurrence of
metastases.19 In another study of grade I chondrosarcomas
with lesion sizes ranging from 1 to 40 cm, there were 3 lo-
cal recurrences in tumors smaller than 10 cm. In the present
study, tumor size was evaluated by measuring the largest
diameter of the lesion, which is the current procedure.10,17-
19
 Tumor size did not influence patient prognosis, and no
local recurrences occurred in spite of the size ranging from
2 to 25 cm.
A relationship between the incidence of recurrences and
the location of the primary lesion has also not been estab-
lished. In the study of 40 patients with grade I chondrosar-
comas, local recurrences occurred in 1 of 5 extracom-
partmental lesions and 2 of 35 intracompartmental lesions.10
In a study of 14 patients with grade I chondrosarcomas, lo-
cal recurrence was observed in 7 of 11 extracompartmental
lesions, 2 of 2 intracompartmental lesions, and in 1 of 1
indeterminate lesion.20 In another study of 17 patients with
grade I chondrosarcomas, only one local recurrence was
noted, and it occurred in an intracompartmental lesion.8 In
the present study in which 6 tumors were
extracompartmental and 16 were intracompartmental, no
local recurrence or metastases occurred; therefore, the lo-
cation of the primary tumor did not influence the clinical
outcome.
There is not a consensus regarding the amount of fol-
low-up time required after surgery regarding patients with
chondrosarcomas. Some authors assert that a follow-up of
2 years is adequate, while others consider a of 5 years as a
minimum.5,10,17,19,21,22 Recurrences and metastases in low-
grade lesions occur less frequently for the first time after 5
years, and the possibility of metastases occurring before a
local recurrence is very low .5,6,23 In a study of 40 patients
with grade I chondrosarcomas, recurrence occurred in 3 pa-
tients, 1, 3, and 6 years after surgery.10 In a second study of
patients with grade I pelvic chondrosarcomas, recurrences
occurred on average 77 months after surgery, but no
metastases were detected.19 In a third study, patients with
grade I chondrosarcomas undergoing intralesional resec-
tions, it was found that 10 patients experienced recurrence,
7 of them before 5 years of follow-up.20 In a fourth study,
in patients with grade I chondrosarcomas, a mild change in
recurrence after 5 years of follow-up was detected.24 There-
fore, patients with grade I chondrosarcomas must be fol-
lowed-up for at least 5 years, preferably for 10 years. The
analysis of this series will probably experience some mild
alterations after 5 years of minimum follow-up because in
this series the minimum follow-up is 2 years with an aver-
age of 6 years.
Chondrosarcomas have a poor response to radiotherapy
and chemotherapy. This may be explained by the fact that
its growth is mainly due to matrix production and not so
much to DNA replication.8 This is probably one of the rea-
sons why surgery is the treatment of choice and the type of
resection is a determining factor in prognosis.6,8,9,18,21
The terms adequate or inadequate surgical procedures
have been regarded as important factors influencing prog-
nosis in chondrosarcomas.2 An inadequate surgical proce-
dure refers to a surgery in which there is violation of the
tumor bed and contamination. Some authors report that an
inadequate surgical procedure increases the risk of recur-
rence and metastases.5-7,19,21,22,25 However, the presence of a
local recurrence of a grade I chondrosarcoma presents a low
risk of developing metastases.9,10,19,20,23 Therefore, a local re-
currence in grade I chondrosarcomas does not represent a
poor prognosis, especially when it occurs in the lower ex-
tremities because of the possibility of resection. Therefore,
many authors propose that less aggressive surgical treatment
of grade I chondrosarcomas will not compromise the prog-
nosis.10,12,20,22
The good oncological result obtained in this series of
patients undergoing intralesional resections shows that this
is a valid form of treatment for medullary grade I chondro-
sarcomas, as has been demonstrated by other authors.12,26
In this series, 3 patients were treated only with curettage
without the use of adjuvant therapy and did not experience
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recurrence after 24, 35, and 37 months of follow-up. These
good outcomes brings into question the malignant nature
of these lesions, similarly to the reported series of 23 pa-
tients undergoing intralesional resection with only 2 recur-
rences.10
An important issue is whether the functional results ob-
tained through intralesional resection justify its use in cases
of grade 1 chondrosarcomas, especially in regions fre-
quently involved, such as the distal femur and proximal hu-
merus, in which wide resections and placement of
endoprosthesis seem too aggressive. Bauer et al.10 conclude
that the more aggressive procedure results in considerable
morbidity and therefore should only be performed in tumors
with a higher risk of local recurrence or metastases, which
is not the case in grade I chondrosarcomas.
The most frequent complication was fracture. In spite
of the fact that the fractures occurred in the distal femur,
the correlation between fracture and location was not sig-
nificant, since the distal femur was also the most frequent
site of the tumor. Also the complication rates did not differ
between group receiving intralesional resections and that
receiving wide/radical resections.
There was a tendency towards better functional results
with the intralesional resections, possibly because the pro-
cedure is less aggressive with greater preservation of the
adjacent tissue. However this relationship could not be
proven because of the small number of patients who had
tumors located in many different locations, making the func-
tion analysis impossible.
Good results, as described in this series, require the elimi-
nation of tumor cells in the region adjacent to the tumor, which
is accomplished by resection of the tumor margins, but by a
simple inadequate intralesional resection. Our findings indi-
cate that less aggressive procedures, such as intralesional re-
sections with local adjuvants, can be safe for treatment of low-
grade medullary grade I chondrossarcomas and may be the
method of choice in non-expendable bones. The medullary
chondrosarcomas located in expendable bones such as the
proximal fibula, iliac wing, and clavicle can be resected in
block. The same technique is indicated for peripheral grade I
chondrosarcomas. A longer follow up and a meta-analysis in-
cluding many papers probably will confirm that the in-block
resections are not the best treatment of grade I medullary chon-
drosarcomas in non-expendable bones.
RESUMO
ETCHEBEHERE M e col. Evolução dos pacientes com
condrossarcoma grau I em relação ao tipo de tratamento
cirúrgico. CLINICS 60(2):121-126, 2005.
OBJETIVO: Avaliar a evolução oncológica de
portadores de condrossarcomas grau I de acordo com o tipo
de tratamento cirúrgico efetuado. Existe controvérsia em
relação à necessidade de ressecções agressivas para
obtenção de uma evolução clínica favorável.
MATERIAIS E MÉTODOS: Os prontuários de 23
portadores de condrossarcoma grau I foram analisados. A
idade dos pacientes variou de 11 a 70 anos com média de
38,4 anos, 52% eram homens e 48% mulheres. O local mais
acometido foi o fêmur com 13 pacientes. Dezessete lesões
(74%) foram classificadas como IA e seis (26%) como IB.
Setenta e quatro por cento dos tumores eram medulares,
22% eram periféricas e uma lesão indeterminada. O
tamanho dos tumores variou de 2 a 25 cm, média de 7,9
cm. Onze pacientes foram submetidos a ressecção
intralesional, nove a ressecção ampla e três a ressecção radi-
cal. O seguimento variou de 24 a 192 meses.
RESULTADOS: Complicações não oncológicas
ocorreram em sete pacientes. Nenhum dos pacientes
apresentou recidiva local ou metástase. Estes dados sugerem
que os procedimentos cirúrgicos menos agressivos são
seguros para o tratamento dos pacientes com
condrossarcoma grau I.
UNITERMOS: Condrossarcoma. Resultado de
tratamento. Curetagem.
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